Cases 1 - 10 of 59
Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc. et al
as 1:2018cv01224
Defendant:
Par Pharmaceutical Companies, Inc. and Par Pharmaceuticals, Inc.
Plaintiff:
Horizon Therapeutics, LLC
Cause Of Action: 35 U.S.C. § 271
Shire-NPS Pharmaceuticals, Inc. v. Par Pharmaceutical Companies, Inc. et al
as 1:2018cv01115
Defendant:
Par Pharmaceutical Companies, Inc., Par Sterile Products, LLC and Par Pharmaceutical, Inc.
Plaintiff:
Shire-NPS Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
INDIVIOR INC. et al v. PAR PHARMACEUTICAL, INC. et al
as 2:2018cv05293
Plaintiff:
INDIVIOR INC. , INDIVIOR UK LIMITED and AQUESTIVE THERAPEUTICS, INC.
Defendant:
PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES INC. and ENDO INTERNATIONAL PLC
Cause Of Action: 15 U.S.C. § 1126
INDIVIOR INC. et al v. PAR PHARMACEUTICAL, INC. et al
as 2:2018cv01780
Plaintiff:
INDIVIOR INC. , INDIVIOR UK LIMITED and AQUESTIVE THERAPEUTICS, INC.
Defendant:
PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES INC. and ENDO INTERNATIONAL PLC
Cause Of Action: 15 U.S.C. § 1126
INDIVIOR INC. et al v. PAR PHARMACEUTICAL INC et al
as 2:2017cv07997
Plaintiff:
INDIVIOR INC. and INDIVIOR UK LIMITED
Defendant:
PAR PHARMACEUTICAL INC, PAR PHARMACEUTICAL COMPANIES INC. and ENDO INTERNATIONAL PLC
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. PAR PHARMACEUTICAL, INC. et al
as 2:2017cv03159
Plaintiff:
CELGENE CORPORATION
Defendant:
PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES, INC., TEVA PHARMACEUTICALS USA, INC. and others
Cause Of Action: 35 U.S.C. § 271
Eli Lilly and Company et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00456
Plaintiff:
Eli Lilly and Company , Eli Lilly Export S.A. and Acrux DDS Pty Ltd.
Defendant:
Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. PAR PHARMACEUTICAL, INC. et al
as 1:2017cv01219
Plaintiff:
ACRUX DDS PTY LTD, ELI LILLY AND COMPANY and ELI LILLY EXPORT S.A.
Defendant:
PAR PHARMACEUTICAL, INC. and PAR PHARMACEUTICALS COMPANIES, INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Shire-NPS Pharmaceuticals, Inc. v. Ambio, Inc. et al
as 1:2017cv00397
Plaintiff:
Shire-NPS Pharmaceuticals, Inc.
Defendant:
Ambio, Inc. , AmbioPharm, Inc. , Par Pharmaceutical Companies, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00040
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Par Pharmaceutical, Inc. , Par Pharmaceutical Companies, Inc. and Par Formulations Private Limited
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.